SEC Tracker
Get the app

Aspen Neuroscience ASPE

Aspen Neuroscience: Ownership stake disclosure

Schedule 13D on Aspen Neuroscience (ASPE), filed with the SEC on Nov 9, 2026, 7:29 pm ET. Source: the filing on SEC EDGAR.

Ownership stake disclosure by ARCH Venture Fund X, L.P.

Form
Schedule 13D
Filed
Importance
Notable
  1. AVF X purchased 187,182 shares of Series Seed Preferred Stock in 2018 at $5.34 per share.
  2. AVF X and AVF X Overage each bought 298,258 shares of Series A-1 Preferred Stock in 2020 at $16.76 per share.
  3. AVF X and AVF X Overage each bought 295,490 shares of Series B Preferred Stock in 2022 at $28.77 per share.

Written from the Schedule 13D on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Aspen Neuroscience files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.